| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
SAN JOSE, Calif.—In June, Thermo Fisher Scientific acquired HighChem, a developer of mass spectrometry software based in Bratislava, Slovakia. Financial and other terms of the transaction were not disclosed. The company provides software that is used by pharmaceutical and metabolomics laboratories for analyzing complex data and identifying small molecules.
 
“Our customers rely on us to provide advanced software solutions that interpret data quickly and accurately to make compound identification simple and understandable,” said Mitch Kennedy, president of chromatography and mass spectrometry at Thermo Fisher Scientific. “The addition of HighChem’s software solutions to our existing mass spectrometry software portfolio will enable us to deliver greater value for our mass spectrometry customers.”
 
HighChem will be integrated into Thermo Fisher’s chromatography and mass spectrometry business, which is part of the firm’s Analytical Instruments unit.
 
As a leading provider of life-sciences technology globally, Thermo Fisher Scientific works to help customers accelerate research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Its premier brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services.

Related Topics

Published In

Volume 15 - Issue 7 | July 2019

July 2019

July 2019 Issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue